Soleno Therapeutics Inc

SLNODelisted May 18, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001484565

SEC filings (opens in a new tab)

Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Soleno Therapeutics Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of SLNO: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	23	54	+31
Shares	5.10M	20.3M	+15.2M (+298.2%)
Value	$21.8M	$598.8M	+$577.0M (+2,645.6%)

New holders (36)

Institutions that held Soleno Therapeutics Inc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to SLNO in Q3 2023
Institution	Shares	Value	% of portfolio
Vivo Capital, LLC	3,203,093	$94.5M	11.70%
Janus Henderson Group PLC	2,204,053	$65.0M	0.04%
Adage Capital Partners GP, L.L.C.	1,327,000	$39.2M	0.09%
Ra Capital Management, L.P.	1,239,000	$36.6M	0.72%
Fairmount Funds Management LLC	1,142,473	$33.7M	4.06%
Commodore Capital LP	887,500	$26.2M	3.06%
Ikarian Capital, LLC	536,720	$15.8M	5.88%
Frazier Life Sciences Management, L.P.	464,937	$13.7M	0.91%
Balyasny Asset Management LLC	458,823	$13.5M	0.04%
Farallon Capital Management, L.L.C.	388,000	$11.4M	0.06%
Silverarc Capital Management, LLC	370,000	$10.9M	4.07%
Soleus Capital Management, L.P.	325,000	$9.59M	0.97%
Woodline Partners LP	263,860	$7.79M	0.09%
Emerald Advisers, LLC	248,674	$7.34M	0.36%
Emerald Mutual Fund Advisers Trust	201,326	$5.94M	0.36%
EAM Investors, LLC	139,330	$4.11M	0.79%
Logos Global Management LP	125,000	$3.69M	0.53%
Boothbay Fund Management, LLC	108,377	$3.20M	0.11%
Parkman Healthcare Partners LLC	100,000	$2.95M	0.54%
683 Capital Management, LLC	87,000	$2.57M	0.26%
Millennium Management LLC	55,456	$1.64M	0.00%
Moore Capital Management, LP	50,000	$1.48M	0.04%
Altium Capital Management LP	47,081	$1.39M	0.80%
Walleye Capital LLC	46,244	$1.36M	0.02%
Citadel Advisors LLC	40,625	$1.20M	0.00%
Morgan Stanley	33,100	$976.8K	0.00%
Maplelane Capital, LLC	25,000	$737.8K	0.08%
Maven Securities LTD	25,000	$737.8K	0.08%
Schonfeld Strategic Advisors LLC	23,200	$684.6K	0.01%
SEI Investments Co	13,571	$400.5K	0.00%
Captrust Financial Advisors	10,186	$300.6K	0.00%
Bank of New York Mellon Corp	9,487	$280.0K	0.00%
Sassicaia Capital Advisers LLC	8,655	$255.4K	12.02%
Northern Trust Corp	7,030	$207.5K	0.00%
Clayton Partners LLC	7,000	$206.6K	0.18%
Citigroup Inc	103	$3.04K	0.00%

Sold out (5)

Institutions that held Soleno Therapeutics Inc at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of SLNO in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
AIGH Capital Management LLC	364,306	$1.56M
Birchview Capital, LP	245,127	$1.05M
Worth Venture Partners, LLC	90,858	$389.8K
UBS Group AG	15	$64
Northwestern Mutual Wealth Management Co	1	$4